TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) ...
Gujarat based Concept Medical, a multinational medical devices company, has announced that it has received its fourth Investigational Device Exemption (IDE) approval from the United States Food and ...
The US FDA has granted an Investigational Device Exemption (IDE) approval for Concept Medical Inc’s novel MagicTouch Sirolimus Coated Balloon (SCB) for the treatment of Small Vessels (SV) in coronary ...
The MAGICAL-ISR study aims to assess the safety and efficacy of this Sirolimus DCB in treating ISR, focusing on the proportion of patients avoiding Target Lesion Failure (TLF) within one-year ...
TAMPA, Fla., Jan. 16, 2025 /CNW/ -- Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrolment of the first patient in the "MAGICAL ...
US FDA, on the 25 th of April 2023, granted the third IDE approval for Concept Medical's Sirolimus Coated Balloon – MagicTouch SCB. Along with this latest IDE approval for the treatment of Small ...
The concept of the integrated development environment is gaining wide attention in the system-on-chip industry. When most people speak of an IDE, they are focused only on software, and indeed the ...
Google has introduced Antigravity, an agent-first IDE built around Gemini 3 and other LLMs that enters the AI IDE arena ...
California: Concept Medical Inc. (CMI) announced that it has been granted second Investigational Device Exemption (IDE) approval in below the knee (BTK) indication for its Sirolimus-coated balloon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback